Denise Daniel
General Practice · Daytona Beach, FLNPI 1235336744
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Novo Nordisk accounts for 83.5% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for general practice clinicians in FL, where the typical reported total is $253.
Across 2 payments — averaging $40.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$68
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$13
Across 254 payments — averaging $7742.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$725K
- AbbVie$428K
- Genentech, Inc.$361K
- Roche Molecular Systems, Inc.$141K
- Eli Lilly$132K
- GSK$130K
- plus $49K from 2 others
What the payments were for
- Food & beverage$82100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 1 | $68 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
How this compares
$82 in reported general payments places this provider in the 25th percentile of 6,901 general practice providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 12 | $48,388 |
| Xtampza ErOxycodone Myristate | 25 | $25,543 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 149 | $9,663 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 294 | $7,835 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 241 | $6,364 |
| Buprenorphine | 11 | $3,978 |
| Oxycodone Hcl | 160 | $3,875 |
| Gabapentin | 147 | $2,972 |
| Alprazolam | 167 | $2,925 |
| Morphine Sulfate ErMorphine Sulfate | 108 | $2,530 |
| Aripiprazole | 19 | $1,972 |
| Pregabalin | 58 | $1,821 |
| Quetiapine Fumarate | 25 | $1,547 |
| Zolpidem Tartrate | 64 | $1,257 |
| Clonazepam | 76 | $1,234 |
Paid to pharmacies, not to this prescriber.
Other general practice in Daytona Beach
- Robert VogelPalm Beach Gardens$1M
- Bruce OuelletteWest Palm Beach$724K
- Caley CasteleinMiami Beach$586K
- Sarah JockinTampa$308K
- Mario RomeroSarasota$275K
- Robert RitterJupiter$233K
- Robert AltharPensacola$231K
- Florencia ZiemkeWest Palm Beach$208K
- Ausberto HidalgoPembroke Pines$171K
- Rickie FergusonPembroke Pines$170K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.